AU2001246876A1 - Remedies - Google Patents

Remedies

Info

Publication number
AU2001246876A1
AU2001246876A1 AU2001246876A AU4687601A AU2001246876A1 AU 2001246876 A1 AU2001246876 A1 AU 2001246876A1 AU 2001246876 A AU2001246876 A AU 2001246876A AU 4687601 A AU4687601 A AU 4687601A AU 2001246876 A1 AU2001246876 A1 AU 2001246876A1
Authority
AU
Australia
Prior art keywords
remedies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001246876A
Inventor
Ikunoshin Kato
Eiji Kobayashi
Tuo-Ping Li
Kaori Nishimura
Hiromu Ohnogi
Hiroaki Sagawa
Masahiro Shiraga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takara Bio Inc
Original Assignee
Takara Shuzo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Shuzo Co Ltd filed Critical Takara Shuzo Co Ltd
Publication of AU2001246876A1 publication Critical patent/AU2001246876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/06—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with flavouring ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2001246876A 2000-04-10 2001-04-10 Remedies Abandoned AU2001246876A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2000108602 2000-04-10
JP2000-108602 2000-04-10
JP2000308522 2000-10-06
JP2000-308522 2000-10-06
JP2001019167 2001-01-26
JP2001-19167 2001-01-26
PCT/JP2001/003074 WO2001076614A1 (en) 2000-04-10 2001-04-10 Remedies

Publications (1)

Publication Number Publication Date
AU2001246876A1 true AU2001246876A1 (en) 2001-10-23

Family

ID=27343046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001246876A Abandoned AU2001246876A1 (en) 2000-04-10 2001-04-10 Remedies

Country Status (8)

Country Link
US (2) US20040002423A1 (en)
EP (2) EP1666051A3 (en)
JP (1) JP2009269927A (en)
KR (2) KR100842693B1 (en)
CN (1) CN100457124C (en)
AU (1) AU2001246876A1 (en)
TW (2) TWI313605B (en)
WO (1) WO2001076614A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1666051A3 (en) * 2000-04-10 2009-10-07 Takara Bio, Inc. Remedies
KR100768024B1 (en) 2001-04-10 2007-10-18 다카라 바이오 가부시키가이샤 Remedies
KR20040013137A (en) * 2001-07-13 2004-02-11 다카라 바이오 가부시키가이샤 Remedies
EP1360959A1 (en) * 2002-05-10 2003-11-12 Schering Aktiengesellschaft Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
KR20050059059A (en) * 2002-08-09 2005-06-17 다카라 바이오 가부시키가이샤 Remedy
JP2004099503A (en) * 2002-09-09 2004-04-02 Nonogawa Shoji Kk Hgf production promoter and cosmetic containing the same
DK1542543T3 (en) 2002-09-23 2014-02-03 Haas Inc John I Hopic acids as a substitute for antibiotics in animal feed
CA2501017A1 (en) * 2002-10-01 2004-04-15 Takara Bio Inc. Remedies
WO2004043475A1 (en) * 2002-11-12 2004-05-27 Takara Bio Inc. Agent for improving learning and memorizing abilities
DE10256031A1 (en) * 2002-11-30 2004-06-09 Nateco 2 Gmbh & Co. Kg Process for the preparation of a xanthohumol-enriched hop extract and its use
CN1791393A (en) * 2003-04-08 2006-06-21 麒麟麦酒株式会社 Composition for inhibition or prevention of bone density lowering and refreshment therefor
WO2005072064A2 (en) * 2004-01-28 2005-08-11 Merina Benny Antony A preparation, process and a regenerative method and technioue for prevention, treatment and glycemic control of diabetes melletus
CA2812755A1 (en) 2004-02-23 2005-09-29 Sss Acquisition, Llc Feeds containing hop acids and uses thereof as supplements in animal feeds
JP2005272355A (en) * 2004-03-25 2005-10-06 Tsuno Rice Fine Chemicals Co Ltd Agent for ameliorating cerebral function
JP2007063130A (en) * 2004-03-31 2007-03-15 Kureha Corp Anti-diabetic composition
US20060069042A1 (en) * 2004-09-24 2006-03-30 Hu Oliver Y Cytochrome P450 2C9 inhibitors
US7531624B2 (en) * 2004-12-03 2009-05-12 Medtrain Technologies, Llc Nuclear targeting sequence
JP5097983B2 (en) * 2005-02-22 2012-12-12 学校法人東京農業大学 Method for producing composition having antioxidant activity
KR100720973B1 (en) * 2005-03-18 2007-05-22 주식회사 유니젠 Composition comprising isoorientin for suppressing histamine
KR100823155B1 (en) * 2005-11-09 2008-04-21 한국생명공학연구원 Novel catecholic xanthone compounds, and composition containing extract of Cudrania tricuspidata or catecholic xanthone compounds isolated therefrom for the prevention and treatment of cardiovascular disease
JP4990534B2 (en) * 2006-02-02 2012-08-01 ポーラ化成工業株式会社 Caffeoylquinic acid derivative and composition for suppressing plasminogen activator inhibitor comprising the same as an active ingredient
WO2007091613A1 (en) * 2006-02-07 2007-08-16 University Of Tsukuba Prophylactic or therapeutic agent for alzheimer's disease, and food/beverage
JP2007230946A (en) * 2006-03-02 2007-09-13 Nagase & Co Ltd Neurite-extending agent
DE102006062264A1 (en) * 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Use of xanthohumol for the prevention and / or control of liver diseases
JPWO2009107878A1 (en) * 2008-02-29 2011-07-07 株式会社 伊藤園 Vegetable extract containing adenine at high concentration, adenine-containing container-packed beverage containing the vegetable extract, oral antihypertensive composition comprising the vegetable extract as an active ingredient, and a method for producing the same
KR101067905B1 (en) * 2008-10-22 2011-09-27 동아대학교 산학협력단 Paper mulberry stem bark having antihyperglycemia activity
US8969419B2 (en) 2009-04-21 2015-03-03 John I. Haas Animal feed compositions and feeding methods
EP2392325A1 (en) * 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
US20130202724A1 (en) * 2010-08-06 2013-08-08 Hadasit Medical Research Services And Development Ltd. Soybean extracts for the treatment of hepatic disorders
CN103237556B (en) 2010-10-04 2016-03-16 韩国韩医学研究院 Comprise the compositions for preventing or treat dementia of Fructus Mume extract
WO2012046993A2 (en) * 2010-10-04 2012-04-12 한국한의학연구원 Composition for preventing or treating dementia containing prunus mume extract
CN102692472B (en) * 2011-03-22 2015-10-21 河北以岭医药研究院有限公司 A kind of content assaying method of hydroxyl radical carthamin yellow carthamus A
KR101384351B1 (en) * 2012-02-14 2014-04-14 충북대학교 산학협력단 Composition for Treating Ischemic Brain Disease Comprising Extract from Rose Flower As Active Ingredient
JP6031662B2 (en) * 2012-02-29 2016-11-24 株式会社漢方医科学研究所 Cognitive decline improvement composition
JP2015520225A (en) 2012-06-22 2015-07-16 アントニー, マリア, ベニーANTONY, Merina, Benny Costus Pictus Obtained from extracts of DON plants and methods for preparing the same
KR20150019505A (en) * 2013-08-14 2015-02-25 대화제약 주식회사 Pharmaceutical Compositions comprising flavone-6-C-glucose derivatives for treating or preventing neuropsychiatric disorders
JP6261263B2 (en) * 2013-09-30 2018-01-17 ハウス食品グループ本社株式会社 Turmeric extract-containing beverage
JP6855157B2 (en) * 2014-10-06 2021-04-07 扶桑化学工業株式会社 Feed for aquatic animals, growth improver for aquatic animals, and breeding methods for farmed fish using them
CN104352457A (en) * 2014-11-24 2015-02-18 四川九章生物科技有限公司 Chlorogenic acid crystal form-containing preparation and application thereof
WO2016117705A1 (en) * 2015-01-23 2016-07-28 株式会社ニューロゲン Agent for inducing production of hepatocyte growth factor
KR102637811B1 (en) * 2015-11-03 2024-02-19 푸락 바이오켐 비.브이. Antibacterial agents containing xanthohumol and their use in food
CN105412083B (en) * 2015-11-12 2018-07-03 江苏康缘药业股份有限公司 The application of isopimpinellin
CN105343052B (en) * 2015-11-12 2018-07-03 江苏康缘药业股份有限公司 The application of RADIX PEUCEDANI aglycon
CN105193787B (en) * 2015-11-12 2018-03-23 江苏康缘药业股份有限公司 The application of byak-angelicin
CN105213364B (en) * 2015-11-12 2018-03-23 江苏康缘药业股份有限公司 The application of khellactone
CN105248456B (en) * 2015-11-30 2018-07-13 南京中医药大学 With the active Chinese medical extract of anti-rot Ditylenchus dipsaci and its application
CN105842371B (en) * 2016-06-03 2017-07-04 山东大学 5 O [4 ' O (β D glucopyranosyls) coffee acyl] quininic acid content assaying method in caulis lonicerae
CN107028927B (en) * 2017-06-05 2021-02-26 中国药科大学 Application of aspirin C and analogues thereof in preparation of liver regeneration drugs
JP7217120B2 (en) * 2018-09-28 2023-02-02 サッポロビール株式会社 Beer-taste beverage and method for producing the same
KR102054129B1 (en) * 2018-11-20 2020-01-22 대한민국 A composition comprising extracts of Safflower seed and Korean dandelion for preventing or treating cognitive dysfunction
WO2020116382A1 (en) * 2018-12-06 2020-06-11 サントリーホールディングス株式会社 Composition for suppressing blood pressure elevation and method for suppressing blood pressure elevation
JP7352570B2 (en) * 2018-12-06 2023-09-28 サントリーホールディングス株式会社 Composition for improving blood flow and composition for improving vascular endothelial function
CN109674777A (en) * 2019-01-16 2019-04-26 中国科学院成都生物研究所 Application of the isochlorogenic acid class compound in preparation neurodegenerative disease and hypochondriacal drug
JP2020176064A (en) * 2019-04-15 2020-10-29 共栄化学工業株式会社 Composition for hair growth
KR102511861B1 (en) * 2022-10-14 2023-03-20 주식회사 함소아제약 Composition for strengthening muscle strength comprising a complex extract of Angelica keiskei and Morus alba leaves

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3924017A (en) * 1972-07-28 1975-12-02 Gen Foods Corp Sweetness inducer
US4345417A (en) * 1981-02-17 1982-08-24 Deere & Company Forage harvester with kernel processing means
JPH07110812B2 (en) * 1990-12-11 1995-11-29 財団法人喫煙科学研究財団 Nerve growth factor biosynthesis promoter
JPH0578384A (en) * 1991-03-27 1993-03-30 Taisho Pharmaceut Co Ltd Flavonol derivative
JPH05201860A (en) * 1992-01-28 1993-08-10 Kitsuen Kagaku Kenkyu Zaidan Agent for accelerating biological synthesis of nervous growth factor
US5788971A (en) * 1993-10-21 1998-08-04 Sky. Food Co., Ltd. Active oxygen free radical scavenging agent
JPH07285856A (en) * 1994-04-21 1995-10-31 Hoechst Japan Ltd Therapeutic agent for osteoporosis
JP2816664B2 (en) * 1996-01-11 1998-10-27 ノブヨシ ハギノ Anti-dementia agent
US5720304A (en) * 1996-03-01 1998-02-24 Omura; Yoshiaki Method of treatment of some resistant infections, cancer and other diseases which have infection and localized metal deposits in pathological areas
FR2750606B1 (en) * 1996-07-03 1999-01-29 Maurel Sante ORGANOMETALLIC COMPLEXES BASED ON SITOSTEROLS AND DIGLYCERIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
CN1087608C (en) * 1996-08-29 2002-07-17 中国人民解放军军事医学科学院放射医学研究所 Use of dicafeoyl quininic acid in treatment of hepatitis B and diseases associated with retrovirus and cafeoyl quininic acid derivs.
JP3974729B2 (en) * 1999-08-19 2007-09-12 ハウス食品株式会社 Neural cell extension agent
JP4629822B2 (en) * 1999-12-02 2011-02-09 長瀬産業株式会社 Nerve growth factor synthesis promoter
KR100378830B1 (en) * 1999-12-11 2003-04-07 김구환 Method of making hangover solution drink
EP1666051A3 (en) * 2000-04-10 2009-10-07 Takara Bio, Inc. Remedies
US20030203857A1 (en) * 2000-04-11 2003-10-30 Hiromu Ohnogi Remedies
KR100381441B1 (en) * 2000-06-14 2003-04-26 기장 메디칼 주식회사 The percutaneous form using moxa and moxa mixed with medical plant, making method and using method thereof
KR20040013137A (en) * 2001-07-13 2004-02-11 다카라 바이오 가부시키가이샤 Remedies

Also Published As

Publication number Publication date
EP1666051A3 (en) 2009-10-07
US20040002423A1 (en) 2004-01-01
KR100842693B1 (en) 2008-07-01
KR100858860B1 (en) 2008-09-17
CN100457124C (en) 2009-02-04
CN1422159A (en) 2003-06-04
WO2001076614A1 (en) 2001-10-18
US20060147558A1 (en) 2006-07-06
KR20080014928A (en) 2008-02-14
TW200817024A (en) 2008-04-16
KR20030013382A (en) 2003-02-14
JP2009269927A (en) 2009-11-19
TWI313605B (en) 2009-08-21
EP1277473A4 (en) 2005-12-28
EP1277473A1 (en) 2003-01-22
EP1666051A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU3837300A (en) Remedies
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2001267135A1 (en) Medicaments
AU2001226668A1 (en) Crankshaft-starter-generator